• Fund Type: Open-End Fund
  • Objective: Market Neutral
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Biotechnology Fund

+ Add to Watchlist

RYCFX:US

62.65 USD 0.41 0.66%

As of 09:29:30 ET on 07/11/2014.

Snapshot for Rydex Series - Biotechnology Fund (RYCFX)

Year To Date: +11.20% 3-Month: +16.04% 3-Year: +29.27% 52-Week Range: 49.24 - 70.14
1-Month: +0.53% 1-Year: +25.75% 5-Year: +26.42% Beta vs SPX: 1.11

Mutual Fund Chart for RYCFX

No chart data available.
  • RYCFX:US 62.65
  • 1M
  • 1Y
Interactive RYCFX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYCFX

Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.

Inception Date: 03-30-2001 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / MIKE DELLAPA
Web Site: www.guggenheiminvestments.com

Fundamentals for RYCFX

NAV (on 2014-07-11) 62.65
Assets (M) (on 2014-07-11) 436.67
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYCFX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for RYCFX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.36

Top Fund Holdings for RYCFX

Filing Date: 06/30/2014
Name Position Value % of Total
Gilead Sciences Inc 340,192 28,205,319 7.043%
Amgen Inc 198,954 23,550,185 5.881%
Biogen Idec Inc 68,201 21,504,457 5.370%
Celgene Corp 246,514 21,170,622 5.286%
Alexion Pharmaceuticals Inc 85,074 13,292,813 3.319%
Vertex Pharmaceuticals Inc 139,752 13,231,719 3.304%
Regeneron Pharmaceuticals Inc 44,119 12,462,294 3.112%
Illumina Inc 67,346 12,023,955 3.002%
Incyte Corp Ltd 138,369 7,809,546 1.950%
BioMarin Pharmaceutical Inc 119,774 7,451,141 1.861%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil